BTTX

Better Therapeutics, Inc.

0.05 USD
+0.05 (+15,600.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Better Therapeutics, Inc. stock is up 371% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 July’s closed higher than June.

About Better Therapeutics, Inc.

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. Its lead product candidate in development is BT-001, a platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure.